Qi Zhang

机构：Northeast Agricultural University, National Institute of Diabetes and Digestive and Kidney Diseases, Guangzhou Vocational College of Science and Technology, National Center for Advancing Translational Sciences, Tsinghua University · ORCID：0000-0002-2639-9158

发表论文 72 篇 · 总被引 12417 次 · h-index 25

代表论文

• Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses (2022 · Nature Communications · 被引 76)
• Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation (2023 · Nature Communications · 被引 30)
• Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2 (2022 · Structure · 被引 29)
• Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection (2022 · Scientific Reports · 被引 24)
• Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2 (2022 · Frontiers in Immunology · 被引 22)
• SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters 1 (2023 · Emerging Microbes & Infections · 被引 17)